You are here

CME

CME Activities: New Free CME Courses

  • Current Strategies for the Long-term Assessment, Monitoring, and Management of Cystic Fibrosis Patients Treated with CFTR Modulator Therapy

     

    Faculty: J. Stuart Elborn, MD (Chair), Jane Davies, MD, Marcus A. Mall, MD, Patrick A. Flume, MD, Barry Plant, MD

    The content for this activity is based on the satellite symposium, “Current Strategies for the Long-term Assessment, Monitoring, and Management for Cystic Fibrosis Patients Treated with CFTR Modulator Therapy” that was presented at the 39th European Cystic Fibrosis Society Conference on June 10, 2016. The emergence of novel targeted agents, that directly correct CFTR loss function alleles, has created new treatment opportunities for patients with cystic fibrosis with advanced disease. Knowledge of the role of these agents in the clinical setting is quickly evolving and will require physicians stay acquainted with the latest data as well as evidence-based treatment guidelines in order to achieve optimized cystic fibrosis patient care.

    Available credit:

    • 1.5 AMA PRA Category 1 CreditsTM
    • 1.5 CBRN contact hours
    • 1.5 Non-physician
  • New Insights into Disease Progression for the CFTR Modulator-Treated Cystic Fibrosis Patient
     

    Faculty: Susanna A. McColley, MD, Jane Davies, MD, Felix Ratjen, MD, PhD, Manu Jain, MD

    This educational activity is adapted from a live satellite symposium held during the 29th Annual North American Cystic Fibrosis Conference in Phoenix, Arizona. This educational symposium will update clinicians on the changes in disease progression that are now seen in CFTR modulator-treated patients. Expert faculty will present comprehensive case studies and conduct interactive panel discussions to enhance your knowledge in the advanced science of cystic fibrosis and patient management strategies.

    Available credit:

    • 2.00 AMA PRA Category 1 Credit(s)™
    • 2.00 CBRN Contact Hours
    • 2.00 Non-physician
  • The Effect of CFTR Modulation on the Disease Progression of Cystic Fibrosis in the Era of Precision Medicine
     

    Faculty: J. Stuart Elborn, MD , Jane Davies, MD,  Scott Bell, MD, Nico Derichs, MD

    This educational activity is based from a live satellite symposium from the 38th European Cystic Fibrosis Conference held in Brussels, Belgium. The expert faculty for this CME activity will present a comprehensive review of the effects of CFTR modulation therapeutics on cystic fibrosis disease progression. This clinically relevant activity also includes panel discussions with case presentations to advance your skills in caring for cystic fibrosis patients.

    Available credit: 

    • 2.00 AMA PRA Category 1 Credit(s)™
    • 2.00 Non-physician

    An application has been made to the EACCME® for CME Accreditation of this event.

  • Advanced Curriculum for Cystic Fibrosis: Integrating Genomic-Driven Data into Patient-Centered Treatment Strategies
     

    Faculty: J. Stuart Elborn, MD, Professor Isabelle Sermet-Gaudelus, MD, PhD, Patrick A. Flume, MD. Susan Madge, PhD, Frank Cerny, PhD, John P. Clancy, MD, Stacy Bichl, APN, Alison Morton

    An interactive faculty round-table discussion on the state of cystic fibrosis care and the development of strategies to manage and overcome challenges presented by variability of patient characteristics, genomic medicine, and the transition from pediatric to adult care. The goal of the webcast is to provide healthcare providers with practical information, which will update their knowledge on cystic fibrosis pathophysiology, genomics, and clinical trials relating to the rationale of therapeutic selection.

    Available credit: 

    • 1.50 AMA PRA Category 1 Credit(s)™
    • 1.50 Non-physician

Search form


E-Alert

Sign up to the CF Resource Center e-mail alert and enter a raffle to win the Elsevier Text book “Clinical Respiratory Medicine”


Visit the Journal Website


What do you think?

Please take a moment to fill out our reader survey.

Read more